ata-ch-ai-screening-lt4

Evaluates central hypothyroidism (CH) patients for adrenal insufficiency (AI) prior to initiating levothyroxine (L‑T4) replacement. Triggers include consideration of L‑T4 start in central hypothyroidi

SKILL.md

GitHub

Screen central hypothyroidism patients for adrenal insufficiency before levothyroxine

STEP 1 — Gather Information

Confirm CH diagnosis: low or low‑normal free T4 (fT4) with non‑elevated TSH in the setting of pituitary disease; assess hypothyroid symptoms; obtain baseline morning serum cortisol (8‑9 AM) if feasible.

STEP 2 — Rule In / Rule Out

Determine if AI testing is feasible (morning cortisol or ACTH stimulation test can be performed). If not feasible, proceed to empiric glucocorticoid therapy; if feasible, move to biochemical evaluation.

STEP 3 — Classify or Stratify

Interpret morning cortisol: <3 µg/dL suggests AI; >15 µg/dL makes AI unlikely; values 3‑15 µg/dL require low‑dose (1 µg) or standard‑dose (250 µg) ACTH stimulation test, with peak cortisol <18.1 µg/dL indicating AI.

STEP 4 — Decide

If AI is confirmed, initiate glucocorticoid replacement (e.g., hydrocortisone 15‑20 mg daily in divided doses) before starting L‑T4; if AI is ruled out, begin L‑T4 therapy targeting mid‑to‑upper reference range fT4; if testing was not feasible, prescribe empiric glucocorticoid therapy (same dosing) while arranging definitive AI evaluation.

Clinical Guardrails / Mimics / Pitfalls

Do not start L‑T4 without assessing AI due to risk of precipitating adrenal crisis; avoid random cortisol for diagnosis; do not use fludrocortisone in secondary AI; ensure patients receive stress‑dose education and emergency glucocorticoid kit; remember that estrogen can raise total cortisol via CBG, potentially masking AI.

Concrete Clinical Example

A 50‑year‑old man with non‑functioning pituitary adenoma post‑resection presents with low fT4 and normal TSH; morning cortisol is 2.5 µg/dL (<3 µg/dL), confirming AI; he receives hydrocortisone 10 mg on waking and 5 mg in the afternoon before L‑T4 is started.

Source: Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118